GE HealthCare Technologies Inc. (GEHC) Financial Ratios
6 years of historical data (2020–2025) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
↑
10.03
↓-21% vs avg
5yr avg: 12.72
30Y Low10.7·High14.0
P/FCF
↑
18.60
↓-11% vs avg
5yr avg: 20.89
30Y Low14.7·High25.1
P/B Ratio
↑
2.67
↓-30% vs avg
5yr avg: 3.83
30Y Low2.8·High4.8
ROE
↑
21.6%
↓+15% vs avg
5yr avg: 18.7%
30Y Low14%·High92%
Debt/EBITDA
↑
2.99
↑+25% vs avg
5yr avg: 2.40
30Y Low0.1·High3.2
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
GEHC Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
GE HealthCare Technologies Inc. trades at 13.5x earnings, 28% below its 5-year average of 18.9x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a discount of 39%. On a free-cash-flow basis, the stock trades at 18.6x P/FCF, 11% below the 5-year average of 20.9x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $28.0B | $37.8B | $35.9B | $35.4B | $26.5B | — | — |
| Enterprise Value | $33.5B | $43.2B | $42.4B | $42.8B | $33.7B | — | — |
| P/E Ratio → | 13.54 | 18.03 | 18.01 | 25.60 | 13.83 | — | — |
| P/S Ratio | 1.36 | 1.83 | 1.82 | 1.81 | 1.44 | — | — |
| P/B Ratio | 2.67 | 3.56 | 4.15 | 4.84 | 2.76 | — | — |
| P/FCF | 18.60 | 25.07 | 23.15 | 20.66 | 14.70 | — | — |
| P/OCF | 14.09 | 18.99 | 18.39 | 16.86 | 12.54 | — | — |
P/E links to full P/E history page with 30-year chart
GEHC EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
GE HealthCare Technologies Inc.'s enterprise value stands at 10.0x EBITDA, 21% below its 5-year average of 12.7x. The Healthcare sector median is 14.2x, placing the stock at a 29% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.10 | 2.15 | 2.19 | 1.84 | — | — |
| EV / EBITDA | 10.03 | 12.95 | 13.22 | 14.05 | 10.68 | — | — |
| EV / EBIT | 12.13 | 13.48 | 13.73 | 14.73 | 13.31 | — | — |
| EV / FCF | — | 28.71 | 27.34 | 24.95 | 18.69 | — | — |
GEHC Profitability
Margins and return-on-capital ratios measuring operating efficiency
GE HealthCare Technologies Inc. earns an operating margin of 13.4%. ROE of 21.6% indicates solid capital efficiency. ROIC of 13.3% represents solid returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 40.0% | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% | 39.4% |
| Operating Margin | 13.4% | 13.4% | 13.3% | 12.5% | 13.8% | 15.9% | 15.8% |
| Net Profit Margin | 10.1% | 10.1% | 10.1% | 8.0% | 10.4% | 12.8% | 80.7% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | 21.6% | 21.6% | 25.0% | 18.6% | 14.5% | 14.1% | 92.5% |
| ROA | 6.0% | 6.0% | 6.1% | 5.2% | 7.1% | 8.9% | 57.1% |
| ROIC | 13.3% | 13.3% | 13.2% | 11.6% | 11.3% | 13.4% | 14.1% |
| ROCE | 10.8% | 10.8% | 11.2% | 11.1% | 12.6% | 15.0% | 15.4% |
GEHC Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
GE HealthCare Technologies Inc. carries a Debt/EBITDA ratio of 3.0x, which is moderately leveraged (7% below the sector average of 3.2x). Net debt stands at $5.5B ($10.0B total debt minus $4.5B cash). Interest coverage of 7.1x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.94 | 0.94 | 1.08 | 1.35 | 0.90 | 0.03 | 0.03 |
| Debt / EBITDA | 2.99 | 2.99 | 2.93 | 3.24 | 2.74 | 0.13 | 0.14 |
| Net Debt / Equity | — | 0.52 | 0.75 | 1.01 | 0.75 | -0.01 | -0.04 |
| Net Debt / EBITDA | 1.64 | 1.64 | 2.02 | 2.42 | 2.28 | -0.03 | -0.16 |
| Debt / FCF | — | 3.65 | 4.18 | 4.29 | 3.99 | -0.09 | -0.38 |
| Interest Coverage | 7.13 | 7.13 | 6.11 | 5.36 | 29.44 | 72.88 | 42.06 |
GEHC Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.18x means GE HealthCare Technologies Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.00x to 1.18x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.18 | 1.18 | 1.00 | 1.00 | 1.09 | 0.97 | 0.84 |
| Quick Ratio | 0.93 | 0.93 | 0.79 | 0.78 | 0.79 | 0.68 | 0.59 |
| Cash Ratio | 0.50 | 0.50 | 0.30 | 0.28 | 0.20 | 0.08 | 0.15 |
| Asset Turnover | — | 0.56 | 0.59 | 0.60 | 0.67 | 0.67 | 0.71 |
| Inventory Turnover | 5.54 | 5.54 | 5.91 | 5.93 | 5.18 | 5.35 | 6.52 |
| Days Sales Outstanding | — | 69.99 | 81.19 | 80.55 | 79.46 | 78.69 | 56.50 |
GEHC Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
GE HealthCare Technologies Inc. returns 0.9% to shareholders annually — split between a 0.2% dividend yield and 0.7% buyback yield. The payout ratio of 3.1% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 7.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.2% | 0.2% | 0.2% | 0.1% | — | — | — |
| Payout Ratio | 3.1% | 3.1% | 2.8% | 2.6% | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | 7.4% | 5.5% | 5.6% | 3.9% | 7.2% | — | — |
| FCF Yield | 5.4% | 4.0% | 4.3% | 4.8% | 6.8% | — | — |
| Buyback Yield | 0.7% | 0.5% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.9% | 0.7% | 0.2% | 0.1% | 0.0% | — | — |
| Shares Outstanding | — | $460M | $459M | $458M | $454M | $455M | $455M |
Peer Comparison
Compare GEHC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 GEHCYou | $28B | 13.5 | 10.0 | 18.6 | 40.0% | 13.4% | 21.6% | 13.3% | 3.0 |
 SYK | $118B | 36.6 | 21.2 | 27.5 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 BSX | $67B | 23.3 | 20.8 | 18.4 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 EW | $50B | 47.7 | 26.8 | 37.7 | 78.1% | 27.0% | 10.5% | 15.5% | 0.4 |
 PHG | $25B | 25.2 | 10.8 | 24.9 | 45.2% | 8.0% | 7.8% | 6.4% | 3.2 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 MDT | $102B | 22.0 | 14.5 | 19.6 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 ABT | $154B | 11.6 | 16.1 | 24.2 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 BAX | $10B | -11.4 | 27.2 | 31.8 | 30.1% | -2.7% | -14.6% | -1.4% | 14.9 |
 ISRG | $144B | 51.7 | 39.0 | 58.0 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 NVST | $4B | 92.5 | 13.8 | 18.3 | 55.0% | 8.3% | 1.6% | 4.8% | 5.0 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 6 years · Updated daily
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into GEHC consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
GEHC — Frequently Asked Questions
Quick answers to the most common questions about buying GEHC stock.
What is GE HealthCare Technologies Inc.'s P/E ratio?
GE HealthCare Technologies Inc.'s current P/E ratio is 13.5x. The historical average is 18.9x.
What is GE HealthCare Technologies Inc.'s EV/EBITDA?
GE HealthCare Technologies Inc.'s current EV/EBITDA is 10.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.7x.
What is GE HealthCare Technologies Inc.'s ROE?
GE HealthCare Technologies Inc.'s return on equity (ROE) is 21.6%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 31.0%.
Is GEHC stock overvalued?
Based on historical data, GE HealthCare Technologies Inc. is trading at a P/E of 13.5x. Compare with industry peers and growth rates for a complete picture.
What is GE HealthCare Technologies Inc.'s dividend yield?
GE HealthCare Technologies Inc.'s current dividend yield is 0.23% with a payout ratio of 3.1%.
What are GE HealthCare Technologies Inc.'s profit margins?
GE HealthCare Technologies Inc. has 40.0% gross margin and 13.4% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does GE HealthCare Technologies Inc. have?
GE HealthCare Technologies Inc.'s Debt/EBITDA ratio is 3.0x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.